Clinical presentation and outcomes of pre-eclampsia and eclampsia at a national hospital, Kenya: A retrospective cohort study.
Adult
Cohort Studies
Eclampsia
/ epidemiology
Female
Gestational Age
Humans
Hypertension
/ physiopathology
Infant, Newborn
Kenya
/ epidemiology
Middle Aged
Perinatal Death
Pre-Eclampsia
/ epidemiology
Pregnancy
Pregnancy Outcome
/ epidemiology
Prenatal Care
/ methods
Retrospective Studies
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
01
2020
accepted:
02
05
2020
entrez:
6
6
2020
pubmed:
6
6
2020
medline:
18
8
2020
Statut:
epublish
Résumé
Hypertensive disorders in pregnancy including pre-eclampsia are associated with maternal and newborn mortality and morbidity. Early detection is vital for effective treatment and management of pre-eclampsia. This study examines and compares the clinical presentation and outcomes between early- and late-onset pre-eclampsia over a two year period. A retrospective cohort study design which examines socio-demographic characteristics, treatment, outcomes, and fetal and maternal complications among women with early onset of pre-eclampsia (EO-PE) and late onset of pre-eclampsia (LO-PE). De-identified records of women who attended antenatal, intrapartum and postnatal care services and experienced pre-eclampsia at Kenyatta National teaching and referral hospital were reviewed. We used chi square, t-test, and calculated odds ratio to determine any significant differences between the EO-PE and LO-PE cohorts. Out of 620 pre-eclamptic and eclamptic patients' records analyzed; 44 percent (n = 273) exhibited EO-PE, while 56 percent had late onset. Women with EO-PE compared to LO-PE had greater odds of adverse maternal and perinatal outcomes including hemolysis elevated liver enzymes and low platelets (HELLP) syndrome (OR: 4.3; CI 2.0-10.2; p<0.001), renal dysfunction (OR; 1.7; CI 0.7-4.1; p = 0.192), stillbirth (OR = 4.9; CI 3.1-8.1; p<0.001), and neonatal death (OR: 8.5; CI 3.8-21.3; p<0.001). EO-PE was also associated with higher odds of prolonged maternal hospitalization, beyond seven days (OR = 5.8; CI 3.9-8.4; p<0.001), and antepartum hemorrhage (OR = 5.8; CI 1.1-56.4; p<0.001). Neonates born after early onset of pre-eclampsia had increased odds of respiratory distress (OR = 17.0; CI 9.0-32.3, p<0.001) and birth asphyxia (OR: 1.9; CI 0.7-4.8; p = 0.142). The profiles and outcomes of women with EO-PE (compared to late onset) suggest that seriousness of morbidity increases with earlier onset. To reduce adverse neonatal and maternal outcomes, it is critical to identify, manage, referral and closely follow-up pregnant women with pre-eclampsia throughout the pregnancy continuum. This study protocol was approved by Population Council's research ethics Institutional Review Board, Protocol 813, and KNH-UoN Ethics and Research Committee, Protocol 293/06/2017.
Sections du résumé
BACKGROUND
Hypertensive disorders in pregnancy including pre-eclampsia are associated with maternal and newborn mortality and morbidity. Early detection is vital for effective treatment and management of pre-eclampsia. This study examines and compares the clinical presentation and outcomes between early- and late-onset pre-eclampsia over a two year period.
METHODS
A retrospective cohort study design which examines socio-demographic characteristics, treatment, outcomes, and fetal and maternal complications among women with early onset of pre-eclampsia (EO-PE) and late onset of pre-eclampsia (LO-PE). De-identified records of women who attended antenatal, intrapartum and postnatal care services and experienced pre-eclampsia at Kenyatta National teaching and referral hospital were reviewed. We used chi square, t-test, and calculated odds ratio to determine any significant differences between the EO-PE and LO-PE cohorts.
RESULTS
Out of 620 pre-eclamptic and eclamptic patients' records analyzed; 44 percent (n = 273) exhibited EO-PE, while 56 percent had late onset. Women with EO-PE compared to LO-PE had greater odds of adverse maternal and perinatal outcomes including hemolysis elevated liver enzymes and low platelets (HELLP) syndrome (OR: 4.3; CI 2.0-10.2; p<0.001), renal dysfunction (OR; 1.7; CI 0.7-4.1; p = 0.192), stillbirth (OR = 4.9; CI 3.1-8.1; p<0.001), and neonatal death (OR: 8.5; CI 3.8-21.3; p<0.001). EO-PE was also associated with higher odds of prolonged maternal hospitalization, beyond seven days (OR = 5.8; CI 3.9-8.4; p<0.001), and antepartum hemorrhage (OR = 5.8; CI 1.1-56.4; p<0.001). Neonates born after early onset of pre-eclampsia had increased odds of respiratory distress (OR = 17.0; CI 9.0-32.3, p<0.001) and birth asphyxia (OR: 1.9; CI 0.7-4.8; p = 0.142).
CONCLUSIONS
The profiles and outcomes of women with EO-PE (compared to late onset) suggest that seriousness of morbidity increases with earlier onset. To reduce adverse neonatal and maternal outcomes, it is critical to identify, manage, referral and closely follow-up pregnant women with pre-eclampsia throughout the pregnancy continuum.
ETHICAL APPROVAL
This study protocol was approved by Population Council's research ethics Institutional Review Board, Protocol 813, and KNH-UoN Ethics and Research Committee, Protocol 293/06/2017.
Identifiants
pubmed: 32502144
doi: 10.1371/journal.pone.0233323
pii: PONE-D-20-01091
pmc: PMC7274433
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0233323Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
Integr Blood Press Control. 2016 Jul 27;9:79-94
pubmed: 27555797
Am J Obstet Gynecol. 2013 Dec;209(6):544.e1-544.e12
pubmed: 23973398
Stat Med. 1984 Jul-Sep;3(3):199-214
pubmed: 6385187
BMJ. 2005 Mar 12;330(7491):565
pubmed: 15743856
Am J Epidemiol. 2002 Feb 1;155(3):203-9
pubmed: 11821244
BMC Med Res Methodol. 2018 Nov 15;18(1):132
pubmed: 30442102
Semin Neonatol. 2000 Aug;5(3):197-207
pubmed: 10956445
Acta Obstet Gynecol Scand. 2006;85(5):571-8
pubmed: 16752236
Semin Perinatol. 2009 Jun;33(3):130-7
pubmed: 19464502
J Matern Fetal Neonatal Med. 2017 Dec;30(23):2789-2794
pubmed: 28282780
Arch Dis Child. 1987 Jul;62(7):712-6
pubmed: 3632019
Lancet Glob Health. 2015 Jul;3(7):e387-95
pubmed: 26004775
Clin Obstet Gynecol. 2017 Mar;60(1):141-152
pubmed: 27977436
J Matern Fetal Neonatal Med. 2013 Aug;26(12):1228-33
pubmed: 23413799
Pregnancy Hypertens. 2013 Jan;3(1):44-7
pubmed: 26105740
PLoS One. 2014 Mar 21;9(3):e91198
pubmed: 24657964
Am J Obstet Gynecol. 2012 Jun;206(6):470-5
pubmed: 21963308
BMJ. 2006 Feb 25;332(7539):463-8
pubmed: 16497761
Am J Obstet Gynecol. 2008 Sep;199(3):262.e1-6
pubmed: 18771976
Curr Hypertens Rep. 2014 Sep;16(9):473
pubmed: 25135649
Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):391-403
pubmed: 21333604
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004351
pubmed: 23633317
BMC Pregnancy Childbirth. 2010 Feb 23;10 Suppl 1:S3
pubmed: 20233384
BMJ. 2013 Feb 25;346:f894
pubmed: 23440270
Pregnancy Hypertens. 2013 Oct;3(4):199-202
pubmed: 26103796
Reprod Sci. 2015 Mar;22(3):316-21
pubmed: 25001023
Afr J Reprod Health. 2012 Mar;16(1):35-41
pubmed: 22783666
Obstet Gynecol. 2013 Nov;122(5):1122-1131
pubmed: 24150027
J Reprod Immunol. 2017 Sep;123:12-16
pubmed: 28858635
J Clin Diagn Res. 2014 Sep;8(9):JC01-4
pubmed: 25386463
BMC Pregnancy Childbirth. 2019 Jul 29;19(1):270
pubmed: 31357939
Hypertension. 2018 Jul;72(1):24-43
pubmed: 29899139
F1000Res. 2018 Feb 28;7:242
pubmed: 29560262
Lancet. 2014 Sep 20;384(9948):1129-45
pubmed: 24965816
Arch Gynecol Obstet. 2014 Jul;290(1):53-7
pubmed: 24549271
J Family Med Prim Care. 2017 Oct-Dec;6(4):766-769
pubmed: 29564260
BMC Pregnancy Childbirth. 2018 May 31;18(1):199
pubmed: 29855344
Heart. 2004 Dec;90(12):1499-504
pubmed: 15547046
BMC Pregnancy Childbirth. 2015 Mar 29;15:73
pubmed: 25880924